CG
ARLZ

Cutler Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Cutler Group’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-499
Closed – – 5185
2019
Q1 		$0 Buy
+499
New – ﹤0.01% 5211
2018
Q3 		– Sell
-499
Closed – – 5146
2018
Q2 		$0 Hold
499
– – ﹤0.01% 5401
2018
Q1 		$0 Hold
499
– – ﹤0.01% 5883
2017
Q4 		$0 Sell
499
-100
-17% -$164 ﹤0.01% 6740
2017
Q3 		$1K Sell
599
-8,704
-94% -$11.6K ﹤0.01% 5740
2017
Q2 		$12K Sell
9,303
-29,419
-76% -$42.5K ﹤0.01% 4034
2017
Q1 		$82K Buy
38,722
+38,646
+50,850% +$145K ﹤0.01% 1929
2016
Q4 		$0 Sell
76
-3,780
-98% -$17.9K ﹤0.01% 8056
2016
Q3 		$18K Buy
+3,856
New +$17.6K ﹤0.01% 3571

Cutler Group's ARLZ Position: Q2 2019 in Review

Cutler Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2019, closing a stake of 499 shares.

Cutler Group first reported a position in ARLZ in Q3 2016 and held it in 9 quarters. The position peaked at $82K in Q1 2017. 1 fund tracked by Wall St. Rank holds ARLZ as of Q2 2019.

  • Cutler Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Cutler Group sold 499 Aralez Pharmaceuticals Inc. shares in Q2 2019.
  • Cutler Group first reported a position in Aralez Pharmaceuticals Inc. in Q3 2016 and held it in 9 quarters.
  • Cutler Group's Aralez Pharmaceuticals Inc. position peaked at $82K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2019.

Based on Cutler Group's 13F filing for Q2 2019, filed 9 Aug 2019.